284 related articles for article (PubMed ID: 10450509)
1. HLA class II transgenic mice as models of human diseases.
Taneja V; David CS
Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
[TBL] [Abstract][Full Text] [Related]
2. HLA transgenic mice as models of human autoimmune diseases.
Das P; Abraham R; David C
Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
[TBL] [Abstract][Full Text] [Related]
3. HLA transgenic mice as humanized mouse models of disease and immunity.
Taneja V; David CS
J Clin Invest; 1998 Mar; 101(5):921-6. PubMed ID: 9486959
[No Abstract] [Full Text] [Related]
4. Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice.
Taneja V; David CS
Immunol Rev; 2010 Jan; 233(1):62-78. PubMed ID: 20192993
[TBL] [Abstract][Full Text] [Related]
5. Humanized animal models for autoimmune diseases.
Gregersen JW; Holmes S; Fugger L
Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
[TBL] [Abstract][Full Text] [Related]
6. Role of major histocompatibility complex genes in murine collagen-induced arthritis: a model for human rheumatoid arthritis.
David CS; Taneja V
Am J Med Sci; 2004 Apr; 327(4):180-7. PubMed ID: 15084913
[TBL] [Abstract][Full Text] [Related]
7. HLA class II transgenic mice mimic human inflammatory diseases.
Mangalam AK; Rajagopalan G; Taneja V; David CS
Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
[TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of HLA class II and some autoimmune diseases.
Lepage V; Lamm LU; Charron D
Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
[No Abstract] [Full Text] [Related]
9. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis.
Bradley DS; Das P; Griffiths MM; Luthra HS; David CS
J Immunol; 1998 Nov; 161(9):5046-53. PubMed ID: 9794442
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
11. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease.
Kong YC; Flynn JC; Wan Q; David CS
Autoimmunity; 2003; 36(6-7):397-404. PubMed ID: 14669947
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity versus tolerance: analysis using transgenic mice.
Taneja V; David CS
Hum Immunol; 2000 Dec; 61(12):1383-9. PubMed ID: 11163096
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.
Nepom GT
Autoimmunity; 1990; 7(2-3):189-99. PubMed ID: 1716479
[TBL] [Abstract][Full Text] [Related]
15. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.
Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J
J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.
Nishimura Y; Oiso M; Fujisao S; Kanai T; Kira J; Chen YZ; Matsushita S
Int Rev Immunol; 1998; 17(5-6):229-62. PubMed ID: 10036633
[TBL] [Abstract][Full Text] [Related]
17. Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice.
Abraham RS; David CS
Curr Opin Immunol; 2000 Feb; 12(1):122-9. PubMed ID: 10679410
[TBL] [Abstract][Full Text] [Related]
18. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
Zanelli E; Gonzalez-Gay MA; David CS
Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
